These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20363830)

  • 1. Enhancing the credibility of decisions based on scientific conclusions: transparency is imperative.
    Schreider J; Barrow C; Birchfield N; Dearfield K; Devlin D; Henry S; Kramer M; Schappelle S; Solomon K; Weed DL; Embry MR
    Toxicol Sci; 2010 Jul; 116(1):5-7. PubMed ID: 20363830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Framework for use of toxicity screening tools in context-based decision-making.
    Doull J; Borzelleca JF; Becker R; Daston G; DeSesso J; Fan A; Fenner-Crisp P; Holsapple M; Holson J; Craig Llewellyn G; MacGregor J; Seed J; Walls I; Woo YT; Olin S
    Food Chem Toxicol; 2007 May; 45(5):759-96. PubMed ID: 17215066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priority setting for risk assessment--the benefit of human experience.
    Alonzo C; Laborde A
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):692-6. PubMed ID: 16153990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the quality of risk assessments in Canada using a principle-based approach.
    Forristal PM; Wilke DL; McCarty LS
    Regul Toxicol Pharmacol; 2008 Apr; 50(3):336-44. PubMed ID: 18321623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing the ecological risk assessment process.
    Dale VH; Biddinger GR; Newman MC; Oris JT; Suter GW; Thompson T; Armitage TM; Meyer JL; Allen-King RM; Burton GA; Chapman PM; Conquest LL; Fernandez IJ; Landis WG; Master LL; Mitsch WJ; Mueller TC; Rabeni CF; Rodewald AD; Sanders JG; van Heerden IL
    Integr Environ Assess Manag; 2008 Jul; 4(3):306-13. PubMed ID: 18324871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experiences with and impact of health technology assessment on the German Standing Committee of physicians and patients].
    Gibis B; Rheinberger P
    Z Arztl Fortbild Qualitatssich; 2002 Feb; 96(2):82-90. PubMed ID: 11921610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoting transparency of long-term environmental decisions: the Hanford Decision Mapping System pilot project.
    Drew CH; Nyerges TL; Leschine TM
    Risk Anal; 2004 Dec; 24(6):1641-64. PubMed ID: 15660618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis: from science to application.
    Berger ML; Teutsch S
    Med Care; 2005 Jul; 43(7 Suppl):49-53. PubMed ID: 16056009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Conclusions. The precautionary principle: its advantages and risks].
    Tubiana M
    Bull Acad Natl Med; 2000; 184(5):969-93. PubMed ID: 11077719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk characterization: A bridge to informed decision making.
    North DW
    Fundam Appl Toxicol; 1997 Oct; 39(2):81-8. PubMed ID: 9344620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contrast between risk assessment and rules of evidence in the context of international trade disputes: can the US experience inform the process?
    Anderson EL; Hilaire CS
    Risk Anal; 2004 Apr; 24(2):449-59. PubMed ID: 15078316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
    Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
    Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of risk assessment and risk management processes in the derivation of maximum levels for environmental contaminants in food.
    Schneider K; Ollroge I; Clauberg M; Schuhmacher-Wolz U
    Food Addit Contam; 2007 Jul; 24(7):768-76. PubMed ID: 17613062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Policy decision-making under scientific uncertainty: radiological risk assessment and the role of expert advisory groups.
    Mossman KL
    Health Phys; 2009 Aug; 97(2):101-6. PubMed ID: 19590269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrated approach to data management, risk assessment, and decision making.
    Till JE; Grogan HA; Mohler HJ; Rocco JR; Rood AS; Mohler SS
    Health Phys; 2012 Apr; 102(4):367-77. PubMed ID: 22378197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight-of-evidence evaluation in environmental assessment: review of qualitative and quantitative approaches.
    Linkov I; Loney D; Cormier S; Satterstrom FK; Bridges T
    Sci Total Environ; 2009 Sep; 407(19):5199-205. PubMed ID: 19619890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of a specialised risk analysis group in the Veterinary Services of a developing country].
    Urbina-Amarís ME
    Rev Sci Tech; 2003 Aug; 22(2):587-95. PubMed ID: 15884594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.